SK Capital is excited to announce the promotion of two professionals - congratulations to Santi and Scott!
About us
SK Capital is a private investment firm with a disciplined focus on the specialty materials, ingredients and life sciences sectors. Our integrated, multi-disciplinary team utilizes its industry, operating and investment experience to transform businesses into higher performing organizations. SK Capital seeks buyouts, recapitalizations and growth equity investments. We target companies with opportunities for substantial business improvement, and through active engagement with management teams, we invest in the people and processes that drive our long-term strategic and financial goals.
- Website
-
http://www.skcapitalpartners.com
External link for SK Capital Partners
- Industry
- Financial Services
- Company size
- 51-200 employees
- Headquarters
- New York
- Type
- Privately Held
Locations
-
Primary
Get directions
430 Park Ave
New York, 10022, US
-
Get directions
1515 N. Federal Highway, Suite 405
Boca Raton, Fl 33432, US
Employees at SK Capital Partners
Updates
-
We’re pleased to share that SK Capital has entered into exclusive negotiations with LISI Group to acquire Lisi Medical, a leading MedTech CDMO focused on the production of high-precision components and assemblies for robotic-assisted surgery and orthopedic implants. We believe this represents an attractive opportunity to implement our transformational growth strategy and continue delivering critical solutions to customers. See full press release here: https://lnkd.in/eJ69g5xN
-
-
Wishing everyone a safe and joyful Fourth of July!
Luxium Solutions wishes you all a Happy Fourth of July! Here’s to the spirit of freedom — in life, in work, and in innovation. #luxiumsolutions #IndependenceDay #FourthOfJuly
-
-
Wishing a very Happy Canada Day to our colleagues across Canada.
Today, we celebrate Canada and the values that define us: innovation, resilience, and a deep commitment to accessible healthcare. At Apotex, these principles that have guided us since 1974. Proudly founded and headquartered in Toronto, we’ve grown into the largest Canadian-based pharmaceutical company, with more than 4,000 employees in Canada. We’ve invested more than $550 million in Canadian research and development, saved the healthcare system over $50 billion, and filled more than 2.5 billion prescriptions. Today, one in five prescriptions dispensed in Canada is made by Apotex. As A Force for Health, we’re proud of our roots and even more excited about the future we’re building for Canada and beyond. 🎉
-
-
We’re excited to support Axillon Aerospace as they exhibit at the International Paris Air Show from June 16–22.
Axillon Aerospace is excited to announce we will be exhibiting at the International Paris Air Show June 16-22. Our company capabilities in engine and structural composites, fuel containment, antennas, and radomes will be well represented at the show. Come by our booth to learn more or reach out to the team to setup time to meet with us. www.axillonaerospace.com #StrengthThroughInnovation #Aerospace #Composites #FuelContainment #Antennas #Radomes #ParisAirShow #PAS25
-
-
We’re proud to partner with Carlyle in the acquisition of bluebird bio, a leader in gene therapies for severe genetic diseases. This investment reflects SK Capital’s commitment to supporting transformative healthcare platforms and we look forward to working alongside bluebird’s leadership team to help deliver lifechanging therapies to more patients around the world. Bourne Partners served as sole financial advisor to SK Capital and Carlyle. See full press release here: https://lnkd.in/exw8mm85
-
-
We are proud to welcome John Novak to the firm as Managing Director and Head of Business Development. With over 20 years of experience in private equity and investment banking, John will lead our efforts to source and execute new investments across our core sectors. https://lnkd.in/eRDKkPCK..
-
-
We are excited to support the addition of new strategic leaders at Spectrum as the company continues to advance its mission of improving patient outcomes and expanding its impact across key markets. https://lnkd.in/eZbFNZpp
-
SK Capital is pleased to announce the sale of Florachem. https://lnkd.in/ehn4J_GG
-
We’re excited to announce the strategic investment in Spectrum Vascular to support the business in its mission to improve patient care and bring innovative technologies to market. https://lnkd.in/e8a768rC..